These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14692119)

  • 1. [Impaired lipid metabolism: approaches to prevention and therapy].
    Kukharchuk VV
    Vestn Ross Akad Med Nauk; 2003; (11):61-4. PubMed ID: 14692119
    [No Abstract]   [Full Text] [Related]  

  • 2. [New developments in the prevention and treatment of atherosclerosis, ischemic heart disease, hyperlipidemia and other diseases].
    Samsonov MA; Isaev VA
    Vopr Pitan; 1995; (4):33-4. PubMed ID: 7483479
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of one-year treatment with lovastatin on myocardial remodeling and ischemia in patients with coronary artery disease.
    Kerimkulova A; Noruzbaeva A; Lunegova O; Gotfrid I; Mirrakhimov A; Davydova N; Moldokeeva C; Mirrakhimov E
    Anadolu Kardiyol Derg; 2011 Feb; 11(1):16-21. PubMed ID: 21183418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA;
    Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid-lowering drugs in preventing atherosclerosis].
    Patsch JR
    Internist (Berl); 1989 May; 30(5):309-14. PubMed ID: 2661474
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease.
    Cornoldi A; Caminiti G; Marazzi G; Vitale C; Patrizi R; Volterrani M; Miceli M; Fini M; Spera G; Rosano G
    Int J Cardiol; 2010 Jun; 142(1):50-5. PubMed ID: 19361872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is it worthwhile treating the dyslipidemia of patients with coronary disease?].
    Giannini SD
    Arq Bras Cardiol; 1992 Apr; 58(4):253-4. PubMed ID: 1340692
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies in blood lipid metabolism. VI. Serial serum lipid partitions in patients with chronic coronary artery disease.
    GOLDBLOOM AA
    Am Pract Dig Treat; 1952 Oct; 3(10):799-803. PubMed ID: 12986162
    [No Abstract]   [Full Text] [Related]  

  • 9. Citric acid cycle intermediates in cardioprotection.
    Czibik G; Steeples V; Yavari A; Ashrafian H
    Circ Cardiovasc Genet; 2014 Oct; 7(5):711-9. PubMed ID: 25518044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia].
    Santos RD;
    Arq Bras Cardiol; 2001 Nov; 77 Suppl 3():1-48. PubMed ID: 11781591
    [No Abstract]   [Full Text] [Related]  

  • 11. The Quinapril Ischemic Event Trial (QUIET).
    Pitt B
    Blood Press Suppl; 1992; 4():11-2. PubMed ID: 1345328
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease].
    Ose L
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3629-31. PubMed ID: 8539720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary arteriosclerosis and lipid metabolism (hyperlipemia)].
    Nakamura H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():69-74. PubMed ID: 12734955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hyperlipidemia in patients with ischemic heart disease].
    Pauciullo P; Lirato C; Sapio C; Mancini M
    Cardiologia; 1993 Dec; 38(12 Suppl 1):345-8. PubMed ID: 8020035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of coronary atherosclerosis. Determination and evaluation of lipid metabolism values].
    Cremer P; Nagel D; Seidel D
    Fortschr Med; 1995 Nov; 113(32):453-8. PubMed ID: 8543271
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive lipid-lowering in stable patients with coronary artery disease.
    Supanich B
    J Fam Pract; 1999 Oct; 48(10):749-50. PubMed ID: 12224668
    [No Abstract]   [Full Text] [Related]  

  • 18. Should beta-blockers be prescribed more frequently to Japanese patients with coronary artery disease?
    Imamura T
    Circ J; 2010 May; 74(5):848-9. PubMed ID: 20424330
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Najjar SS; Bottomley PA; Schulman SP; Waldron MM; Steffen RP; Gerstenblith G; Weiss RG
    J Cardiovasc Magn Reson; 2005; 7(4):657-66. PubMed ID: 16136855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposal of human chylomicrons administered intravenously in ischemic heart disease and essential hyperlipemia.
    NESTEL PJ; DENBOROUGH MA; O'DEA J
    Circ Res; 1962 May; 10():786-91. PubMed ID: 14479079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.